ENHO and metabolic dysfunction-associated steatotic liver disease: In our study, we did not find significant correlations between adropin and circulating inflammatory biomarkers, such as hs-CRT and TNF-alpha, whereas in other studies that mainly involved patients with non-alcoholic fatty liver disease, circulating adropin was inversely associated with inflammation and oxidative stress.